Literature DB >> 30016718

Conformal coating by multilayer nano-encapsulation for the protection of human pancreatic islets: In-vitro and in-vivo studies.

Farooq Syed1, Marco Bugliani2, Michela Novelli3, Francesco Olimpico2, Mara Suleiman2, Lorella Marselli2, Ugo Boggi3, Franco Filipponi3, Vittoria Raffa4, Silke Krol5, Daniela Campani3, Pellegrino Masiello3, Vincenzo De Tata3, Piero Marchetti6.   

Abstract

To improve the efficiency of pancreatic islet transplantation, we performed in-vitro and in-vivo experiments with isolated human pancreatic islets coated by multi-layer nano-encapsulation using differently charged polymers [chitosan and poly(sodium styrene sulfonate)] to obtain up to 9 layers. The islet coating (thickness: 104.2 ± 4.2 nm) was uniform, with ≥ 90% cell viability and well preserved beta- and alpha-cell ultrastructure. Nano-encapsulated islets maintained physiological glucose-stimulated insulin secretion by both static incubation and perifusion studies. Notably, palmitate- or cytokine-induced toxicity was significantly reduced in nano-coated islets. Xenotransplantation of nano-encapsulated islets under the kidney capsule of streptozotocin-induced C57Bl/6J diabetic mice allowed long term normal or near normal glycemia, associated with minimal infiltration of immune cell into the grafts, well preserved islet morphology and signs of re-vascularization. In summary, the multi-layer nano-encapsulation approach described in the present study provides a promising tool to effectively protect human islets both in-vitro andin-vivo conditions.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Human islets; Immune isolation; Islets transplantation; Multilayer nanoencapsulation

Mesh:

Substances:

Year:  2018        PMID: 30016718     DOI: 10.1016/j.nano.2018.06.013

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  8 in total

Review 1.  Nanotechnology in cell replacement therapies for type 1 diabetes.

Authors:  Alexander U Ernst; Daniel T Bowers; Long-Hai Wang; Kaavian Shariati; Mitchell D Plesser; Natalie K Brown; Tigran Mehrabyan; Minglin Ma
Journal:  Adv Drug Deliv Rev       Date:  2019-02-02       Impact factor: 15.470

Review 2.  Engineering the vasculature for islet transplantation.

Authors:  Daniel T Bowers; Wei Song; Long-Hai Wang; Minglin Ma
Journal:  Acta Biomater       Date:  2019-05-23       Impact factor: 8.947

Review 3.  Type 1 diabetes and engineering enhanced islet transplantation.

Authors:  Abiramy Jeyagaran; Chuan-En Lu; Aline Zbinden; Andreas L Birkenfeld; Sara Y Brucker; Shannon L Layland
Journal:  Adv Drug Deliv Rev       Date:  2022-08-21       Impact factor: 17.873

Review 4.  Nanotechnology Approaches to Modulate Immune Responses to Cell-based Therapies for Type 1 Diabetes.

Authors:  Sydney C Wiggins; Nicholas J Abuid; Kerim M Gattás-Asfura; Saumadritaa Kar; Cherie L Stabler
Journal:  J Diabetes Sci Technol       Date:  2019-09-06

5.  Optimization of Islet Microencapsulation with Thin Polymer Membranes for Long-Term Stability.

Authors:  Shota Toda; Artin Fattah; Kenta Asawa; Naoko Nakamura; Kristina N Ekdahl; Bo Nilsson; Yuji Teramura
Journal:  Micromachines (Basel)       Date:  2019-11-06       Impact factor: 2.891

Review 6.  Nanotechnology in Kidney and Islet Transplantation: An Ongoing, Promising Field.

Authors:  Wei Wang; Ya Teng; Ji-Ji Xue; Hong-Kai Cai; Yu-Biao Pan; Xing-Nan Ye; Xin-Li Mao; Shao-Wei Li
Journal:  Front Immunol       Date:  2022-04-08       Impact factor: 8.786

Review 7.  Immune-Protective Formulations and Process Strategies for Improved Survival and Function of Transplanted Islets.

Authors:  Yannan Shi; Ying-Zheng Zhao; Zhikai Jiang; Zeqing Wang; Qian Wang; Longfa Kou; Qing Yao
Journal:  Front Immunol       Date:  2022-07-12       Impact factor: 8.786

Review 8.  The Current Status of Bioartificial Pancreas Devices.

Authors:  Sara J Photiadis; Rebecca C Gologorsky; Deepika Sarode
Journal:  ASAIO J       Date:  2021-04-01       Impact factor: 3.826

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.